Pancreatic cancer treatment with cannabinoids
Disease | Treatment | Patient(s) | Results | Ref. |
---|---|---|---|---|
Pancreatic cancer (advanced, metastatic disease) | pure CBD, 400 mg per day, concomitant to standard chemotherapy (2 patients with CBD as the only treatment) | 9 patients; mean age at diagnose 49.7 years (range 45–70 years); 5 women, 4 men | The mean overall survival was 11.5 months (median 11 months) and seems to be longer than the overall survival reported in the literature for metastatic disease (5.9 months) | [132] |